These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9626379)

  • 1. Stability of enalapril maleate in three extemporaneously prepared oral liquids.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1998 Jun; 55(11):1155-7. PubMed ID: 9626379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of extemporaneous enalapril maleate suspensions for pediatric use prepared from commercially available tablets.
    Sosnowska K; Winnicka K; Czajkowska-Kośnik A
    Acta Pol Pharm; 2009; 66(3):321-6. PubMed ID: 19645333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1998 Sep; 55(18):1915-20. PubMed ID: 9784772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.
    Casas M; Álvarez J; Lucero MJ
    Pharm Dev Technol; 2015 May; 20(3):271-8. PubMed ID: 24279906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of microcalorimetry in determination of stability of enalapril maleate and enalapril maleate tablet formulations.
    Simoncic Z; Zupancic P; Roskar R; Gartner A; Kogej K; Kmetec V
    Int J Pharm; 2007 Sep; 342(1-2):145-51. PubMed ID: 17597314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of rifabutin in two extemporaneously compounded oral liquids.
    Haslam JL; Egodage KL; Chen Y; Rajewski RA; Stella V
    Am J Health Syst Pharm; 1999 Feb; 56(4):333-6. PubMed ID: 10690216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of degradation of enalapril maleate in dosage forms.
    Stanisz B
    Acta Pol Pharm; 2004; 61(6):415-8. PubMed ID: 15794332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C.
    Abdel-Rahman SM; Nahata MC
    Am J Health Syst Pharm; 1999 Feb; 56(3):243-5. PubMed ID: 10030510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence of enalapril oral solution for treatment of pediatric hypertension and enalapril tablets.
    Moffett BS; DiSanto AR; Espinosa O; Hou J; Colabuono P
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):493-8. PubMed ID: 27129124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations.
    Al-Omari MM; Abdelah MK; Badwan AA; Jaber AM
    J Pharm Biomed Anal; 2001 Jul; 25(5-6):893-902. PubMed ID: 11377072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles.
    Brustugun J; Lao YE; Fagernaes C; Braenden J; Kristensen S
    Am J Health Syst Pharm; 2009 Oct; 66(19):1722-5. PubMed ID: 19767378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of captopril in SyrSpend SF.
    Geiger CM; Sorenson B; Whaley PA
    Int J Pharm Compd; 2013; 17(4):336-8. PubMed ID: 24261148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril maleate polymorphs: instability of form II in a tablet formulation.
    Eyjolfsson R
    Pharmazie; 2002 May; 57(5):347-8. PubMed ID: 12061263
    [No Abstract]   [Full Text] [Related]  

  • 16. Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Oct; 53(19):2304-9. PubMed ID: 8893069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of famotidine in an extemporaneously prepared oral liquid.
    Quercia RA; Jay GT; Fan C; Chow MS
    Am J Hosp Pharm; 1993 Apr; 50(4):691-3. PubMed ID: 8470686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications.
    Lima DM; dos Santos LD; Lima EM
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):934-7. PubMed ID: 18472382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of stability of enalapril maleate in solid phase.
    Stanisz B
    J Pharm Biomed Anal; 2003 Feb; 31(2):375-80. PubMed ID: 12609677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.